bupropion hydrochloride (sr)

Generic: bupropion hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (sr)
Generic Name bupropion hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-5101
Product ID 50090-5101_65817f64-2d82-4dc7-8a8a-cab01892826a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206122
Listing Expiration 2026-12-31
Marketing Start 2016-08-17

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500905101
Hyphenated Format 50090-5101

Supplemental Identifiers

RxCUI
1801289
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (sr) (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA206122 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)
source: ndc

Packages (2)

50090-5101-0 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0) 50090-5101-1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE (SR) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "65817f64-2d82-4dc7-8a8a-cab01892826a", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["1801289"], "spl_set_id": ["994229b0-e190-49e3-83ce-6a2063f7335a"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-0)", "package_ndc": "50090-5101-0", "marketing_start_date": "20200713"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5101-1)", "package_ndc": "50090-5101-1", "marketing_start_date": "20200713"}], "brand_name": "BUPROPION HYDROCHLORIDE (SR)", "product_id": "50090-5101_65817f64-2d82-4dc7-8a8a-cab01892826a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5101", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206122", "marketing_category": "ANDA", "marketing_start_date": "20160817", "listing_expiration_date": "20261231"}